Pancreatin Multienzymes tablets 0.25g №20 Vitaminy

Pancreatin Multienzymes tablets 0.25g №20 Vitaminy

Product Code: 8155
Availability: In Stock

Ask a question about this product


active substance:pancreatin;

1 tablet contains Pancreatin 250 mg, corresponding to the activity of at least 1000 amylolytic UNITS Ph. Eur., 1200 pH lipolytic MEALS. Eur., 80 PH proteolytic MEALS. Eur .;

excipients: lactose monohydrate, povidone, calcium stearate acryl-C pink 9ZOZ4055 (mixture of substances: methacrylate copolymer type C, talc, titanium dioxide (E 171) triethyl citrate; Carmine (E 120), silicon dioxide colloidal, sodium bicarbonate, sodium lauryl sulfate; ponso 4R (E124) 132)).


Dosage form

Tablet coated liner.

Basic physical and chemical properties:tablets of round shape, coated with a smooth, beveled, from light pink to dark pink color, allowed the presence of specific odor. On the fault line when considering under a magnifying glass shows a core surrounded by one continuous layer.


drug description

means to improve digestion, including enzymes. Multienzyme preparations.

PBX Code A09A A02.


Pharmacological properties


the Enzyme preparation from the pancreas of cattle and pigs. Pancreatic enzymes included in the preparation-lipase, a-amylase, trypsin, chymotrypsin-facilitate the digestion of proteins, carbohydrates and fats, contributing to a more complete absorption of nutrients in the small intestine.


Due to the Acid-resistant coating of the enzyme is not inactivated under the action of the hydrochloric acid of the stomach. Dissolution of the membrane and release of enzymes begins in the duodenum. Enzymes are poorly absorbed in the digestive tract, act in the lumen of the intestine.


dyspepsia simultaneous consumption of vegetable, fatty and unusual food, difficult to digest; flatulence associated with the above disorders; acceleration of passage of food in the intestine of a functional nature.


Hypersensitivity to Pancreatin or to one of the components of the drug. Acute pancreatitis, chronic pancreatitis in the stage of exacerbation, intestinal obstruction.

Interaction with other medicinal products and other forms of interaction.

with the simultaneous use of Pancreatin with antithrombic agents, vitamin K antagonists and acetylsalicylic acid, the effect of these drugs decreases. The effectiveness of non-selective monoamine reuptake inhibitors is also reduced while their use with Pancreatin.

While the use of M-anticholinergics increases anticholinergic effect.

when using the drug may reduce the absorption of iron, folic acid, reduce the hypoglycemic effect of acarbose.

concomitant use of calcium carbonate and/or magnesium hydroxide antacids with tannin and alcohol-containing agents May lead to a decrease in the effectiveness of Pancreatin.

application Features

Intestinal obstruction - in the presence of symptoms reminiscent of this condition, it is necessary to remember the possibility of intestinal strictures. It is recommended to monitor for any unusual symptoms, especially when taking more than 10,000 units of lipase/kg/day.

uric acid content in urine should be monitored to avoid the formation of uric acid concrements.

the Drug contains active enzymes that can damage the mucous membrane of the oral cavity, so the tablets should be swallowed whole, without chewing.

with prolonged use, iron preparations should be prescribed at the same time.

when taking the drug before meals, it should be washed down with alkaline liquids (for example, mineral water "Borjomi" or 0.5-1% sodium bicarbonate solution).

use during pregnancy or lactation.

Pancreatin can be used during pregnancy and lactation only when prescribed by a physician in cases where the expected benefit to the mother exceeds the potential risk to the fetus/child.

Ability to influence the reaction rate when driving motor transport or operating other mechanisms.

has No effect.

Method of application and doses

Adults and children over 6 years of age take 1-2 tablets orally, during or immediately after meals, without chewing, with plenty of liquid.

depending on the kind of food, or the degree of severity of digestive disorders during the meal with the aim fermentativnoi therapy apply 2-4 tablets.

the Dose and duration of treatment is determined by the nature of the disease and is set individually.


the Drug can be used in children aged 6 years.


Symptoms:hyperuricemia, hyperuricosuria; in children constipation.

when using the drug in high doses in children may experience perianal skin irritation.

Treatment:withdrawal of the drug, adequate hydration, symptomatic therapy.

Side effects

from the digestive system: diarrhea, discomfort in the epigastric area of the stomach, nausea, vomiting, flatulence, changes in the nature of the chair, constipation, intestinal obstruction.

Allergic reactions:hypersensitivity reactions are possible (including rash, itching, sneezing, lacrimation, bronchospasm, urticaria, anaphylactic reactions).


shelf Life

2 years old.

storage Conditions

Store in its original packaging at a temperature not exceeding 25 ° C.

keep out of reach of children.



there are 10 tablets in a blister, № 10x1 or 10x2, or 10x5, or 10x6 blisters in the cardboard pack.


Category vacation

over the counter.


the Manufacturer/applicant

OJSC "Vitaminy".

the manufacturer's Location and address of the place of business/location of the applicant and/or the applicant's representative.

Ukraine, 20300, Cherkasy region, G. . Uman, Leninskaya Iskra str., 31.


Pancreatin tablets 0.25 g # 20 – an intestinal-soluble drug aimed at compensating for the insufficiency of the external secretory function of the pancreatic.& nbsp; Means consists of enzymes (amylase, lipase, protease), facilitating the process of digestion, improving the process of absorption of proteins, fats, carbohydrates. The medication is indicated at:

  • Inflammatory processes in the stomach, liver, gall bladder.
  • Diarrhea, cystic fibrosis, flatulence, digestive disorders.
  • The
  • Chronic pancreatitis.

the Medication is used to pre-prepare patients for ultrasound examination of the peritoneum.

application Features

the Correct dosage is determined based on weight, age and features of the specific pathology. The average recommended rate of 150 thousand units per day (adults). Children up to 1.5 years is assigned to the 15 000 units per day. The maximum possible daily dose is 400 thousand units. The total duration of drug therapy varies depending on the type and severity of the disease. The drug is contraindicated in exacerbation of chronic pancreatitis, hypersensitivity to certain components. Before the reception requires a doctor's consultation and examination of the digestive tract.

Write a review

Note: HTML is not translated!
    Bad           Good

Recently viewed © 2019